Search
Taysha Gene Therapies Inc
TSHAAdd to Watchlist
6.650USD
-0.160-2.35%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM
Taysha Gene Therapies Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
9.77M
17.28%
EPS(YoY)
-0.34
4.50%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its total revenue reached 9.77M, with a year-on-year change of 17.28.
What are the current assets of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its current assets were 324.65M, with a year-on-year change of 128.42.
What are the total assets of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its total assets of Taysha Gene Therapies Inc were 343.32M, with a year-on-year change of 114.09.
What are the total liabilities of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its total liabilities of Taysha Gene Therapies Inc were 96.38M, with a year-on-year change of 8.49.
What is the total equity of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its total equity of Taysha Gene Therapies Inc was 246.94M, with a year-on-year change of 245.25.
What is the net investment of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its net investment of Taysha Gene Therapies Inc was -604.00K, with a year-on-year change of -66.39.
What is the net financing of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its net financing of Taysha Gene Therapies Inc was 274.59M, with a year-on-year change of 258.08.
What is the Earnings Per Share (EPS) of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.34, with a year-on-year change of 4.50.
What is the net margin of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its net profit margin was -1115.27, with a year-on-year change of -4.07.
What is the debt-to-asset ratio of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its debt-to-asset ratio was 14.70, with a year-on-year change of -47.26.
What is the Return on Equity (ROE) of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its Return on Equity (ROE) was -68.45, with a year-on-year change of 43.87.
What is the Return on Assets (ROA) of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its Return on Assets (ROA) was -43.28, with a year-on-year change of 19.28.
What is the operating profit of Taysha Gene Therapies Inc?
According to Taysha Gene Therapies Inc's FY2025 earnings report, its operating profit was -110.50M, with a year-on-year change of -27.56.